Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Goebell · SciRah

Researcher profile · Semantic Scholar

P. Goebell

Share profile

P. Goebell — researcher profile on SciRah

h-index: 33
Works: 177
Citations: 4,248

Most-cited papers

SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.
C. Eichelberg, W. Vervenne, M. De Santis, Ludwig Fischer von Weikersthal +16 more
2015European Urology140 citations Open access
Semantic Scholar
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials
S. Burdett, D. Fisher, C. Vale, A. Bono +16 more
2021European Urology115 citations Open access
Semantic Scholar
68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
C. Schmidkonz, M. Cordes, D. Schmidt, T. Bäuerle +9 more
2018European Journal of Nuclear Medicine and Molecular Imaging106 citations
Semantic Scholar
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
P. Dürr, K. Schlichtig, Carolin Kelz, Birgit Deutsch +19 more
2021Journal of Clinical Oncology79 citations Open access
Semantic Scholar
99mTc‐MIP‐1404‐SPECT/CT for the detection of PSMA‐positive lesions in 225 patients with biochemical recurrence of prostate cancer
C. Schmidkonz, Claudia Hollweg, M. Beck, Julia Reinfelder +11 more
2018The Prostate79 citations
Semantic Scholar
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients
S. Williams, A. Kamat, K. Chamie, M. Froehner +10 more
2018European Urology Oncology65 citations Open access
Semantic Scholar
Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
W. Kassouf, S. Traboulsi, B. Schmitz-Dräger, J. Palou +6 more
2016Urologic oncology65 citations
Semantic Scholar
Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials—Analyses From the German Clinical RCC Registry
N. Marschner, M. Staehler, L. Müller, A. Nusch +4 more
2017Clinical Genitourinary Cancer54 citations Open access
Semantic Scholar
68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients
C. Schmidkonz, M. Cordes, T. Goetz, O. Prante +6 more
2019Annals of Nuclear Medicine46 citations
Semantic Scholar
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
C. Schmidkonz, M. Cordes, M. Beck, T. Goetz +8 more
2018Clinical Nuclear Medicine46 citations
Semantic Scholar
First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer
Julia Reinfelder, T. Kuwert, M. Beck, James C. Sanders +7 more
2017Clinical Nuclear Medicine40 citations
Semantic Scholar
Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.09.006: A Statement from the International Bladder Cancer Network.
S. Williams, P. Black, L. Dyrskjøt, R. Seiler +5 more
2019European Urology35 citations
Semantic Scholar
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
A. Kahlmeyer, C. Stöhr, A. Hartmann, P. Goebell +4 more
2019Journal of Clinical Medicine34 citations Open access
Semantic Scholar
Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.
B. Schmitz-Dräger, E. C. Kuckuck, T. Zuiverloon, E. Zwarthoff +16 more
2016Urologic oncology34 citations
Semantic Scholar
CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer
Q. Pan, A. Sathe, P. Black, P. Goebell +3 more
2017Bladder Cancer31 citations Open access
Semantic Scholar
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
D. Sikic, B. Keck, S. Wach, H. Taubert +8 more
2017PLoS ONE31 citations Open access
Semantic Scholar
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
A. Kramar, S. Négrier, R. Sylvester, S. Joniau +80 more
2015Annals of Oncology31 citations Open access
Semantic Scholar
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
N. Benderska-Söder, J. Hovanec, B. Pesch, P. Goebell +19 more
2020Urologic oncology30 citations
Semantic Scholar
PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels
C. Schmidkonz, T. Goetz, T. Kuwert, P. Ritt +4 more
2019Annals of Nuclear Medicine30 citations
Semantic Scholar
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
S. Williams, Hogan Hudgins, Mohamed D. Ray-zack, K. Chamie +17 more
2018European Urology Oncology29 citations Open access
Semantic Scholar
Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience
M. Retz, P. de Geeter, P. Goebell, U. Matz +2 more
2015BMC Cancer28 citations Open access
Semantic Scholar
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer
C. Schmidkonz, M. Cordes, M. Beck, T. Goetz +9 more
2018Clinical Nuclear Medicine23 citations
Semantic Scholar
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study
L. Bergmann, U. Kube, C. Doehn, T. Steiner +9 more
2015BMC Cancer23 citations Open access
Semantic Scholar
Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC‐Registry
P. Goebell, M. Staehler, Lothar Müller, A. Nusch +7 more
2018Clinical Genitourinary Cancer22 citations Open access
Semantic Scholar
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
P. Goebell, P. Ivanyi, J. Bedke, L. Bergmann +9 more
2020Future Oncology20 citations Open access
Semantic Scholar
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study
A. Rogler, Sabine Hoja, J. Giedl, A. Ekici +9 more
2014BMC Cancer19 citations Open access
Semantic Scholar
Treatment Algorithm for Metastatic Renal Cell Carcinoma - Recommendations Based on Evidence and Clinical Practice
L. Bergmann, J. Thaddeus Beck, K. Bothe, O. Brinkmann +12 more
2014Oncology Research and Treatment17 citations Open access
Semantic Scholar
Functional analyses and prognostic significance of SFRP1 expression in bladder cancer
A. Rogler, Emil Kendziorra, J. Giedl, C. Stoehr +8 more
2015Journal of Cancer Research and Clinical Oncology16 citations Open access
Semantic Scholar
Checkpoint modulation - A new way to direct the immune system against renal cell carcinoma
J. Bedke, S. Kruck, G. Gakis, A. Stenzl +1 more
2015Human Vaccines & Immunotherapeutics14 citations Open access
Semantic Scholar
Prognostic Markers in pT3 Bladder Cancer: A Study from the International Bladder Cancer Tissue Microarray Project
Gang-ping Wang, P. Black, P. Goebell, Ling-Yun Ji +10 more
2021Urologic oncology13 citations Open access
Semantic Scholar
Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
P. Goebell, L. Müller, A. Hübner, H. Harich +4 more
2018Urologic oncology13 citations Open access
Semantic Scholar
Temsirolimus in daily use: results of a prospective multicentre noninterventional study of patients with metastatic kidney cancer.
A. Schrader, S. Seseke, C. Keil, E. Herrmann +6 more
2014European Urology12 citations
Semantic Scholar
99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer.
C. Schmidkonz, T. Götz, A. Atzinger, P. Ritt +5 more
2020Clinical Nuclear Medicine11 citations
Semantic Scholar
New horizons in bladder cancer research.
J. Boormans, E. Zwarthoff, P. Black, P. Goebell +5 more
2020Urologic oncology11 citations
Semantic Scholar
Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, Germany
Charlotte Marie Kühn, H. Strasser, A. Romming, B. Wullich +1 more
2015Urologia internationalis10 citations Open access
Semantic Scholar
Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction
Natalie Oginski, H. Apel, M. Richterstetter, V. Lieb +4 more
2022Urologia internationalis9 citations
Semantic Scholar
Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial
M. Staehler, M. Stöckle, D. Christoph, A. Stenzl +11 more
2020International Journal of Cancer9 citations Open access
Semantic Scholar
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example
P. Sekula, Julia Preßler, W. Sauerbrei, P. Goebell +1 more
2016BMJ Open9 citations Open access
Semantic Scholar
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study.
P. Goebell, L. Müller, H. Hurtz, M. Koska +2 more
2016Clinical Genitourinary Cancer8 citations
Semantic Scholar
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial
K. Schlichtig, Lisa Cuba, P. Dürr, Laura Bellut +7 more
2022Journal of Clinical Medicine7 citations Open access
Semantic Scholar
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.
M. Reike, M. Ingersoll, D. C. Müller, T. Zuiverloon +13 more
2022Urologic oncology6 citations Open access
Semantic Scholar
TROPiCS-04: Study of sacituzumab govitecan (SG) in patients (pts) with locally advanced (LA) unresectable or metastatic urothelial cancer (mUC) that has progressed after prior platinum (PLT) and checkpoint inhibitor (CPI) therapy.
C. Vulsteke, P. Grivas, S. Tagawa, J. Bellmunt +10 more
2022Journal of Clinical Oncology6 citations
Semantic Scholar
Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma.
Luca Kümmerl, Matthias Kraulich, W. Lesyuk, A. Binninger +2 more
2023Urologic oncology5 citations Open access
Semantic Scholar
Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
V. Lieb, A. Abdulrahman, K. Weigelt, S. Hauch +9 more
2021Cells5 citations Open access
Semantic Scholar
Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC‐Registry
M. Staehler, P. Goebell, L. Müller, Till-Oliver Emde +4 more
2019International Journal of Cancer5 citations Open access
Semantic Scholar
Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial Carcinoma.
D. Sikic, S. Wach, H. Taubert, M. Richterstetter +7 more
2015Anticancer Research5 citations
Semantic Scholar
Everolimus as second-line therapy for metastatic renal cell carcinoma (mRCC) after one previous VEGF-targeted therapy: Final results of the noninterventional change study.
P. Goebell, U. Kube, M. Staehler, C. Doehn +11 more
20145 citations
Semantic Scholar
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study.
P. Goebell, A. Münch, L. Müller, H. Hurtz +3 more
20145 citations
Semantic Scholar
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.
P. Hensley, R. Seiler, Harry W. Herr, K. Mouw +9 more
2023Urologic oncology4 citations
Semantic Scholar
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study
B. Schmitz-Dräger, E. Bismarck, Dorothee Grammenos, T. Ebert +6 more
2022British Journal of Nutrition4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Wullich×15
Invite
B. Wullich — researcher profile on SciRah
B. Schmitz-Dräger×11
Invite
B. Schmitz-Dräger — researcher profile on SciRah
C. Schmidkonz×8
Invite
C. Schmidkonz — researcher profile on SciRah
O. Prante×8
Invite
O. Prante — researcher profile on SciRah

×8

Invite

T. Kuwert — researcher profile on SciRah

Invite

P. Ritt — researcher profile on SciRah

Invite

A. Kamat — researcher profile on SciRah

N. Marschner×8

Invite

N. Marschner — researcher profile on SciRah

Invite

T. Bäuerle — researcher profile on SciRah

Invite

M. Cordes — researcher profile on SciRah

Invite

T. Goetz — researcher profile on SciRah

Invite

M. Uder — researcher profile on SciRah